IMMUNOSCAPE
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution. The company’s Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information. This technology has been utilized across multiple therapeutic areas, especially in oncology and infectious disease, both to better understand immunotherapy safety and efficacy and to identify drug targets.
IMMUNOSCAPE
Industry:
Biotechnology Life Science Medical
Founded:
2016-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.immunoscape.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
28.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Advisors List
Current Employees Featured
Founder
Investors List
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - ImmunoScape
EDBI
EDBI investment in Venture Round - ImmunoScape
Anzu Partners
Anzu Partners investment in Venture Round - ImmunoScape
Anzu Partners
Anzu Partners investment in Venture Round - ImmunoScape
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - ImmunoScape
NPR Holdings
NPR Holdings investment in Venture Round - ImmunoScape
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Seed Round - ImmunoScape
Key Employee Changes
| Date | New article |
|---|---|
| 2021-02-23 | ImmunoScape Announces Chief Business Officer to Lead U.S. Expansion |
Official Site Inspections
http://www.immunoscape.com Semrush global rank: 4.87 M Semrush visits lastest month: 1.81 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
